Bilimoria, K. Y. et al. Adrenocortical carcinoma in the United States: treatment utilization and prognostic factors. Cancer 113, 3130–3136 (2008).

Article  PubMed  Google Scholar 

Else, T. et al. Adrenocortical carcinoma. Endocr. Rev. 35, 282–326 (2014).

Article  CAS  PubMed  Google Scholar 

Kebebew, E., Reiff, E., Duh, Q. Y., Clark, O. H. & McMillan, A. Extent of disease at presentation and outcome for adrenocortical carcinoma: have we made progress? World J. Surg. 30, 872–878 (2006).

Article  PubMed  Google Scholar 

Tella, S. H., Kommalapati, A., Yaturu, S. & Kebebew, E. Predictors of survival in adrenocortical carcinoma: an analysis from the national cancer database. J. Clin. Endocrinol. Metab. 103, 3566–3573 (2018).

Article  PubMed  Google Scholar 

Tierney, J. F. et al. National treatment practice for adrenocortical carcinoma: have they changed and have we made any progress? J. Clin. Endocrinol. Metab. 104, 5948–5956 (2019).

Article  PubMed  Google Scholar 

Kerkhofs, T. M. et al. Adrenocortical carcinoma: a population-based study on incidence and survival in the Netherlands since 1993. Eur. J. Cancer 49, 2579–2586 (2013).

Article  PubMed  Google Scholar 

McAteer, J. P., Huaco, J. A. & Gow, K. W. Predictors of survival in pediatric adrenocortical carcinoma: a Surveillance, Epidemiology, and End Results (SEER) program study. J. Pediatr. Surg. 48, 1025–1031 (2013).

Article  PubMed  Google Scholar 

Fassnacht, M. et al. Limited prognostic value of the 2004 International Union Against Cancer staging classification for adrenocortical carcinoma: proposal for a revised TNM classification. Cancer 115, 243–250 (2009).

Article  PubMed  Google Scholar 

Elhassan, Y. S. et al. S-GRAS score for prognostic classification of adrenocortical carcinoma: an international, multicenter ENSAT study. Eur. J. Endocrinol. 186, 25–36 (2021).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Beuschlein, F. et al. Major prognostic role of Ki67 in localized adrenocortical carcinoma after complete resection. J. Clin. Endocrinol. Metab. 100, 841–849 (2015).

Article  CAS  PubMed  Google Scholar 

Michalkiewicz, E. et al. Clinical and outcome characteristics of children with adrenocortical tumors: a report from the International Pediatric Adrenocortical Tumor Registry. J. Clin. Oncol. 22, 838–845 (2004).

Article  CAS  PubMed  Google Scholar 

Loncar, Z. et al. Survival and prognostic factors for adrenocortical carcinoma: a single institution experience. BMC Urol. 15, 43 (2015).

Article  PubMed  PubMed Central  Google Scholar 

Li, P., Su, X., Zhang, X., Sun, L. & Zhang, G. Prognostic factors of adrenocortical carcinoma: experience from a Regional Medical Center in Eastern China. Int. J. Gen. Med. 16, 453–465 (2023).

Article  PubMed  PubMed Central  Google Scholar 

Lughezzani, G. et al. The European Network for the Study of Adrenal Tumors staging system is prognostically superior to the International Union Against Cancer-staging system: a North American validation. Eur. J. Cancer 46, 713–719 (2010).

Article  PubMed  Google Scholar 

Terzolo, M. et al. Results of the ADIUVO study, the first randomized trial on adjuvant mitotane in adrenocortical carcinoma patients. J. Endocr. Soc. 5, A166–A167 (2021).

Article  PubMed Central  Google Scholar 

Fassnacht, M. et al. Combination chemotherapy in advanced adrenocortical carcinoma. N. Engl. J. Med. 366, 2189–2197 (2012).

Article  CAS  PubMed  Google Scholar 

Fassnacht, M. et al. European Society of Endocrinology Clinical Practice Guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the Study of Adrenal Tumors. Eur. J. Endocrinol. 179, G1–G46 (2018).

Article  CAS  PubMed  Google Scholar 

Challis, B. G. et al. Familial adrenocortical carcinoma in association with Lynch syndrome. J. Clin. Endocrinol. Metab. 101, 2269–2272 (2016).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gatta-Cherifi, B. et al. Adrenal involvement in MEN1. Analysis of 715 cases from the Groupe d’Etude des Tumeurs Endocrines database. Eur. J. Endocrinol. 166, 269–279 (2012).

Article  CAS  PubMed  Google Scholar 

Hampel, H. et al. Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer). N. Engl. J. Med. 352, 1851–1860 (2005).

Article  CAS  PubMed  Google Scholar 

Herrmann, L. J. et al. TP53 germline mutations in adult patients with adrenocortical carcinoma. J. Clin. Endocrinol. Metab. 97, E476–E485 (2012).

Article  CAS  PubMed  Google Scholar 

MacFarland, S. P. et al. Management of adrenal masses in patients with Beckwith–Wiedemann syndrome. Pediatr. Blood Cancer 64, 10.1002/pbc.26432 (2017).

Article  PubMed Central  Google Scholar 

Pinto, E. M. et al. Identification of clinical and biologic correlates associated with outcome in children with adrenocortical tumors without germline TP53 mutations: a st jude adrenocortical tumor registry and children’s oncology group study. J. Clin. Oncol. 35, 3956–3963 (2017).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Raymond, V. M. et al. Prevalence of germline TP53 mutations in a prospective series of unselected patients with adrenocortical carcinoma. J. Clin. Endocrinol. Metab. 98, E119–E125 (2013).

Article  CAS  PubMed  Google Scholar 

Raymond, V. M. et al. Adrenocortical carcinoma is a Lynch syndrome-associated cancer. J. Clin. Oncol. 31, 3012–3018 (2013).

Article  PubMed  PubMed Central  Google Scholar 

Seki, M. et al. Loss of normal allele of the APC gene in an adrenocortical carcinoma from a patient with familial adenomatous polyposis. Hum. Genet. 89, 298–300 (1992).

Article  CAS  PubMed  Google Scholar 

Shiroky, J. S., Lerner-Ellis, J. P., Govindarajan, A., Urbach, D. R. & Devon, K. M. Characteristics of adrenal masses in familial adenomatous polyposis. Dis. Colon Rectum 61, 679–685 (2018).

Article  PubMed  Google Scholar 

Wakatsuki, S. et al. Adrenocortical tumor in a patient with familial adenomatous polyposis: a case associated with a complete inactivating mutation of the APC gene and unusual histological features. Hum. Pathol. 29, 302–306 (1998).

Article  CAS  PubMed  Google Scholar 

Wasserman, J. D. et al. Prevalence and functional consequence of TP53 mutations in pediatric adrenocortical carcinoma: a Children’s Oncology Group study. J. Clin. Oncol. 33, 602–609 (2015).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Juhlin, C. C. et al. What did we learn from the molecular biology of adrenal cortical neoplasia? From histopathology to translational genomics. Endocr. Pathol. 32, 102–133 (2021).

Article  CAS  PubMed  Google Scholar 

Grisanti, S., Cosentini, D., Sigala, S. & Berruti, A. Molecular genotyping of adrenocortical carcinoma: a systematic analysis of published literature 2019–2021. Curr. Opin. Oncol. 34, 19–28 (2022).

Article  CAS  PubMed  Google Scholar 

Else, T. et al. Adrenocortical carcinoma and succinate dehydrogenase gene mutations: an observational case series. Eur. J. Endocrinol. 177, 439–444 (2017).

Article  CAS  PubMed  Google Scholar 

Grisanti, S. et al. 29MO Germline variants NGS characterization in patients with non-syndromic adrenocortical carcinoma. ESMO Open 8, 101050 (2023).

Article  Google Scholar 

Custodio, G. et al. Impact of neonatal screening and surveillance for the TP53 R337H mutation on early detection of childhood adrenocortical tumors. J. Clin. Oncol. 31, 2619–2626 (2013).

Article  PubMed  PubMed Central  Google Scholar 

Latronico, A. C. et al. An inherited mutation outside the highly conserved DNA-binding domain of the p53 tumor suppressor protein in children and adults with sporadic adrenocortical tumors. J. Clin. Endocrinol. Metab. 86, 4970–4973 (2001).

Article  CAS  PubMed  Google Scholar 

Pinto, E. M. et al. Founder effect for the highly prevalent R337H mutation of tumor suppressor p53 in Brazilian patients with adrenocortical tumors. Arq. Bras. Endocrinol. Metab. 48, 647–650 (2004).

Article  Google Scholar 

Ribeiro, R. C. et al. An inherited p53 mutation that contributes in a tissue-specific manner to pediatric adrenal cortical carcinoma. Proc. Natl Acad. Sci. USA 98, 9330–9335 (2001).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mete, O. et al. Overview of the 2022 who classification of adrenal cortical tumors. Endocr. Pathol. 33, 155–196 (2022).

Article  CAS  PubMed  PubMed Central